Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cortes

Showing results (251-260 of 305) with videos related to

Pageof 31
Sort By:
Journal of Electrocardiology|December 22, 2018
Localization of the culprit artery in inferior myocardial infarction: Influence of the point of measurement of ST segmentBorja Ruiz-Mateos, Rafael García-Borbolla, Manuel Almendro-Delia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemiaH M Kantarjian, S O'Brien, T L Smith, et al.
Leukemia|November 9, 2012
Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantationY Chen, H Kantarjian, S Pierce, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2012
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group StatementS Guiu, S Michiels, F André, et al.
Organic & Biomolecular Chemistry|January 10, 2017
An efficient Ugi-3CR/aza Diels-Alder/Pomeranz-Fritsch protocol towards novel aza-analogues of (±)-nuevamine, (±)-lennoxamine and magallanesine: a diversity oriented synthesis approachÓscar Vázquez-Vera, Jorge S Sánchez-Badillo, Alejandro Islas-Jácome, et al.
Leukemia|June 19, 2013
Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AMLK Takahashi, E Jabbour, X Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2019
Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)R Condorelli, F Mosele, B Verret, et al.
American Journal of Surgery|October 1, 2022
Characterizing injury patterns and outcomes in hospitalized trauma patients with non-English Language PreferencesC H Meyer, A Zeidan, G Beshara, et al.
Leukemia|August 30, 2002
Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factorsM Oosterveld, P Muus, S Suciu, et al.
Neuron|April 19, 2014
Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophyConstanza J Cortes, Shuo-Chien Ling, Ling T Guo, et al.
Pageof 31

Showing results (251-260 of 305) with videos related to

Sort By:
Pageof 31
Journal of Electrocardiology|December 22, 2018
Localization of the culprit artery in inferior myocardial infarction: Influence of the point of measurement of ST segmentBorja Ruiz-Mateos, Rafael García-Borbolla, Manuel Almendro-Delia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemiaH M Kantarjian, S O'Brien, T L Smith, et al.
Leukemia|November 9, 2012
Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantationY Chen, H Kantarjian, S Pierce, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2012
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group StatementS Guiu, S Michiels, F André, et al.
Organic & Biomolecular Chemistry|January 10, 2017
An efficient Ugi-3CR/aza Diels-Alder/Pomeranz-Fritsch protocol towards novel aza-analogues of (±)-nuevamine, (±)-lennoxamine and magallanesine: a diversity oriented synthesis approachÓscar Vázquez-Vera, Jorge S Sánchez-Badillo, Alejandro Islas-Jácome, et al.
Leukemia|June 19, 2013
Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AMLK Takahashi, E Jabbour, X Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2019
Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)R Condorelli, F Mosele, B Verret, et al.
American Journal of Surgery|October 1, 2022
Characterizing injury patterns and outcomes in hospitalized trauma patients with non-English Language PreferencesC H Meyer, A Zeidan, G Beshara, et al.
Leukemia|August 30, 2002
Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factorsM Oosterveld, P Muus, S Suciu, et al.
Neuron|April 19, 2014
Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophyConstanza J Cortes, Shuo-Chien Ling, Ling T Guo, et al.
Pageof 31